Quarterly Result7 May 2026, 06:41 pm
Thyrocare FY26: Revenue Up 20%, PAT Surges 128%
AI Summary
Thyrocare Technologies Ltd. announced its Q4 and full-year results for FY26. The company reported a 20% YoY increase in consolidated revenue for Q4FY26, reaching ₹223.95 crore, and a 128% YoY surge in Profit After Tax to ₹48.70 crore. For FY26, consolidated revenue grew by 21% YoY to ₹829.04 crore, with PAT increasing by 81% YoY to ₹162.85 crore. The company processed 59.0 million tests in Q4FY26, a 29% YoY growth, and expanded its test portfolio with advanced allergy testing and genomics.
Key Highlights
- Q4FY26 revenue grew by 20% YoY to ₹223.95 crore.
- Q4FY26 Profit After Tax (PAT) increased by 128% YoY to ₹48.70 crore.
- FY26 consolidated revenue rose by 21% YoY to ₹829.04 crore.
- FY26 Profit After Tax (PAT) grew by 81% YoY to ₹162.85 crore.
- Processed 59.0 million tests in Q4FY26, a 29% YoY increase.